Home

Pharma China Web Edition

Pharma China Archives

Online Databases

Subscription/Order/Info

Event Calendar

China Pharma Providers

About Us

	News     The Market     Industry News     Regulatory News     General Health     Legal/IPR News     Product/R&D News     API/Bulk Drug News     People in the News     Other News     Top News Worldwide Feature articles     Editorials     Commentaries     Expert Opinions     Interviews     Case Studies     Company Profiles     Editor´s Picks Full Text Title

The Market Industry News Regulatory News General Health Legal/IPR News Product/R&D News API/Bulk Drug News People in the News Other News Top News Worldwide Editorials Commentaries Expert Opinions Interviews Case Studies Company Profiles Editor´s Picks

Big Pharma Cos Witnessed Stunning Growth in Q1, But Has the Chinese Market Outlo... Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with this issue's emphasis on analysis of the surprisingly upbeat Q1 performance and fu... (5/31/2019) Chinese Pharma and Biotech Companies Tap U.S. Talent (6/20/2019) Bribes and Backdoor Deals Help Foreign Firms Sell to China’s Hospitals (6/18/2019) Patient-Centric Trials in China: An Opportunity to Innovate (6/18/2019) WSJ: China Biotechs Lure Industry Talents in the U.S. (6/17/2019) AstraZeneca Markets an Herbal-Based Remedy to Expand in China (6/13/2019) The U.S. Is Purging Chinese Cancer Researchers From Top Institutions (6/13/2019) Analyst Predicts Delay in Medytox's Obtaining Beijing's Nod for Botulinum Toxin (6/13/2019) In Depth: Why China's Drug-Review Revamp Is Stalling (6/13/2019) IBT: China Can Weaponize Prescription Drugs to Hit US in Trade War, Says Expert (6/13/2019) China's Churning Out Revolutionary Cancer Drugs Much Cheaper Than the U.S. (6/13/2019) Health Care Data Compliance in China: FAQ (6/12/2019) Chengdu: The First Steps Towards Mutual Insurance in China (6/11/2019) As Trump's Trade War with China Continues, Fosun Backs Out of US (6/6/2019) Patent Invalidation Strategies in China (6/4/2019) Chinese Policies Fail to Curb Soaring Drug Prices (6/2/2019) NHC Releases 1st Batch of the List of En...  (6/20/2019) NHC Pushes Forward Action Plan for Strea...  (6/20/2019) CDE Seeks Comments on Draft Technical Gu...  (6/20/2019) China Improves Basic Public Healthcare S...  (6/19/2019) (free) Celgene Dips Out of Deals Ahead of Mega-...  (6/19/2019) NHC Releases 2018 Annual Health Sector D...  (6/19/2019) BeiGene and SpringWorks Announce the For...  (6/18/2019) China's Fosun Mulls Joint Bid for Bayer'...  (6/18/2019) Mycovia, Jiangsu Hengrui to Develop and ...  (6/18/2019) IQVIA: Leading Players by Urban Public H...  (6/18/2019) NHSA: Centralized Tender Purchase of Dru...  (6/18/2019) Snapshot of BMI System Financial Perform...  (6/18/2019) NMPA Issues Guidelines for Clinical Safe...  (6/18/2019) NHC: Public Hospitals Receive Increasing...  (6/18/2019) CASI Pharmaceuticals Acquires Worldwide ...  (6/17/2019) PhRMA Calls for Trade Deals That Force Countries to Pay ... IQVIA: Global Pharma to Grow Slower in the Next Five Yea... Pfizer and GSK Announce JV to Create a Global Consumer H... Top 25 Global Pharmaceutical Companies by Market Cap 201... CANbridge Receives IND Approval to Commence CAN008 Phase... IQVIA: Leading Players by Urban Public Hospital Drug Sales in 2... No. of Retail Pharmacies Hits Historical High as Retail Drug Sa... Changing Landscape of Chinese Retail Pharmacy Market IQVIA: Chinese Hospital Drug Market Up 3.3% in MAT 2018 IQVIA: Chinese Retail Pharmacy Sales Up 4.2% in Q4/2018 NHC Releases 1st Batch of the List of Encouraged Generic Dru... Celgene Dips Out of Deals Ahead of Mega-Merger BeiGene and SpringWorks Announce the Formation of JV MapKure... China's Fosun Mulls Joint Bid for Bayer's Animal Health Busi... Mycovia, Jiangsu Hengrui to Develop and Commercialize Antifu... NHC Pushes Forward Action Plan for Streamlined Managemen... CDE Seeks Comments on Draft Technical Guidelines for Cli... NMPA Issues Guidelines for Clinical Safety Literature Ap... NMPA Restores Import of Fabrik Evers' HITRECHOL NMPA Publishes List of Reference Formulations for Generi... US Senators Questions HHS Money and Chinese Genomics Firms European Chamber Report Calls for Urgent China Reforms amid ... NPC Solicits Public Comments on Amendment of the Drug Admini... NPC Solicits Public Comments on Amendment of the Vaccine Man... Bloomberg: U.S. Considers Drug Protection Concession in Chin... Athenex Voluntarily Suspends Production at Its Chongqing... China Issues Draft Positive List of Antibacterial Active... Chinese API Industry's Environmental Shake-up Disrupts V... U.S. Senators Propose Bill to Sanction Chinese Pharmchem... Lonza's Specialty API Business Disrupted by Chinese Plan... Chi-Med Announces Successful Surufatinib Phase III Study... BeiGene Announces Preliminary Phase 2 Results of Tisleli... Beigene Touts 'Encouraging' Response Rates as It Mounts ... Athenex and PharmaEssentia Announce Positive Early Clini... China Approves First Human Trials of 4-Way Norovirus Vac... China Improves Basic Public Healthcare Services NHC Releases 2018 Annual Health Sector Development Repor... NHSA: Centralized Tender Purchase of Drugs to be Expande... Snapshot of BMI System Financial Performance in 01-04/20... NHC: Public Hospitals Receive Increasing Financial Suppo... BeiGene CEO John Oyler Elected to BIO Board of Directors Hansoh Pharma Founder Becomes the Latest Chinese Pharma Bi... Recent Executive Moves Recent Executive Movements Former CFDA Vice Minister Wu Zhen Formally Indicted for Re... China Launches Nasdaq-style Tech Board in Shanghai, Expe... Upcoming Event: Microbiome Movement – Drug Development ... Upcoming Event: Asia-Pacific Pharma IP Leader Summit 201... Upcoming Event: Measuring Business Impact & ROI Upcoming Event: Situational Training Needs Analysis Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector... WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...   WiCON to Hold Pharma China Ann...   WiCON Publishes the China Phar...   WiCON Officially Publishes Chi...   WiCON Officially Publishes Chi...   WiCON and PharmaGuys Launch Ph...

© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links